ISSN: 2161-0681
Journal of Clinical & Experimental Pathology
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
  • Research Article   
  • J Clin Exp Pathol 2014, Vol 4(1): 153
  • DOI: 10.4172/2161-0681.1000153

Effect of Nutrisim on Endotoxic Shock Induced by Lipopolysaccharide from Escherichia coli: 0111:B4 in Rats: Structural Study of Liver, Kidney and Lung

Erika D González-Renovato1, Moisés Alatorre-Jiménez1, Oscar K Bitzer-Quintero2, Sergio Sánchez-Luna1, Luis J Flores-Alvarado3, Rolando Romero-Dávalos4, Luis Romero4, José J Hernández-Andalón4, Genaro G Ortiz1* and Fermín P Pacheco-Moisés
1División de Neurociencias, Laboratorio de Mitocondria, Estrés Oxidativo & Patología, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social. Guadalajara, Jalisco, Mexico
2División de Neurociencias, Laboratorio de Neuroinmunomodulación Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social.Guadalajara, Jalisco, Mexico
3Departamento de Bioquímica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jalisco, Mexico
4Área de Desarrollo e Investigación Científica, Laboratorios BioSim©. Distrito Federal, Mexico
*Corresponding Author: Genaro G Ortiz, División de Neurociencias, Laboratorio de Mitocondria, Estrés Oxidativo & Patología, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Sierra Mojada 800, CP 44340, Guadalajara, Jalisco, Mexico, Tel: +52 33 3638 5593, Email: genarogabriel@yahoo.com

Received: 01-Nov-2013 / Accepted Date: 29-Nov-2013 / Published Date: 04-Dec-2013 DOI: 10.4172/2161-0681.1000153

Abstract

Bacterial Lipopolysaccharide (LPS) is a glycolipid component of the cell wall of Gram-negative bacteria and is an endotoxin implicated in triggering sepsis and septic shock. Sepsis and its sequelae represent a continuum of clinical syndrome encompassing systemic inflammation, coagulopathy, abnormalities of the renal, hepatic, pulmonary, and hematologic systems followed by multi-organ failure. NutriSim©, a nutritional supplement, has previously been tested in an experimental model of septic shock; for example, a single dose of NutriSim© diminishes significantly the production of serum proinflammatory cytokines, attenuates the oxidative stress markers and preserves membrane fluidity in rat liver mitochondria. Therefore, the aim of the present study was to evaluate the protective effect of NutriSim© on survival and histological alterations in liver, kidney and lung associated with endotoxic shock induced by LPS. The results in this work showed that treatment with a single dose of NutriSim© 15 min prior or after LPS challenge, effectively protects the morphological damage in vital organs such as liver, kidney and lung, and improved the survival rate of LPS-treated rats. In conclusion, a single dose of NutriSim© in a septic shock model induced by LPS appears to effectively protect vital organ damage from morphological injury and reduces mortality.

Keywords: NutriSim©; Septic shock; Survival; Liver; Lipopolysaccharide

309518

Introduction

Septic shock can be considered analogous to endotoxic shock or endotoxicosis, and designates the state of acute circulatorymetabolic dysfunction, which is initiated after the release in the body of bacterial endotoxins secondary to a septic process initial or subsequent to the isolated experimental endotoxin administration, respectively. Endotoxins are macromolecular complexes formed by Lipopolysaccharide (LPS), and proteins localized in the outer membrane of Gram-negative bacteria and pathogenesis from these organisms can arise during systemic exposure to either; whole bacteria or their constituents [1]. Recognition of bacterial components such as LPS by the innate immune system triggers the release of potent mediators of inflammation, which result in an exaggerated pathogenic inflammatory response in the circulation and vital organs [2]. Exposure to LPS can produce an array of pathophysiological changes including hypotension and cytotoxic lesions as well as functional and metabolic disturbances in different organs [3,4]. It has been well established that LPS alters cellular redox status [5].

The liver is one of the most important organs with regard to the production and effects of tumor necrosis factor alpha (TNF-α). Liver Kupffer cells or macrophages are major sources of production of TNF-α, in response to bacterial LPS [6]. Furthermore, TNF-α and other pro-inflammatory mediators, such as nitric oxide, superoxide, eicosanoids and interleukin-1 and interleukin-6, are excessively released into circulation which may alter the liver functions, resulting in changes in the integrity of liver vasculature [7] or the regulation of liver cytochrome P450 contents and metabolic capacity [8]. Current evidence indicates that TNF-α production drives mitochondrial reactive oxygen species generation; oxidants must play and into inflammatory mitochondrial damage [9]. Endotoxin accumulates in tissues rich in cells of the reticuloendothelial system such as liver and spleen [10] and induces increasing hepatic levels of end-products of lipid peroxidation such as Malondialdehyde (MDA) and 4-hydroxyalkenals [5]. In addition, bacterial endotoxins induce physiological and morphological changes [11]; in a histological analysis it has been reported that livers from endotoxin-treated animals showed an acute cellular infiltration (especially by polymorphonuclear neutrophils), cloudy swelling of the cells and an eosinophilic cytoplasm [5]. This may be a reason for organ dysfunction upon excessive inflammatory response mediated by endotoxin.

It has been proposed that inhibiting LPS-induced production of these proinflammatory mediators by antioxidants may prevent the pathology of endotoxic shock Antioxidants are substances that react with oxygen free radicals; they stop tissue oxidation by processes involving radical scavenging and other mechanisms [12]. Previously, we showed that a single dose of NutriSim© (10 μl/100 g of body weight), prior or before the endotoxic insult diminishes significantly the production of serum TNF-α, IL-1 and IL-6 [13] and attenuates the oxidative stress markers and preserves membrane fluidity in rat liver mitochondria [14]. NutriSim© is a nutritional supplement that contains arginine, lysine, choline, ammonium chloride, calcium and magnesium. It is used empirically for several degenerative diseases. The aim of the present study was to test the ability of NutriSim© to counteract the effects of the LPS on morphological changes in vital organs and survival.

309520

Materials and Methods

Experimental design

One hundred adult male Wistar rats used for this research work were obtained from CIBO-IMSS (Guadalajara, Jalisco, Mexico). The animals weighed 200-250 g were maintained on a 12 h/12 h lightdark cycle at (22 ± 2°C, fed with standard diet (Purina 5001 (Table 1), for diet composition) and water ad libitum. Lipopolysaccharide (from Escherichia coli, serotype 0111:B4) was purchased from Sigma Chemical Co. (St. Louis, MO, USA), and NutriSim© was acquired from Laboratorios BioSim© (D.F., México). All animals received humane care in accordance with international guidelines on the ethical use of animals, and the “Norma Oficial Mexicana NOM-062-ZOO-1999”.

Nutrients  
Protein, % 23.9
Fat (ether extract), % 5
Cholesterol, ppm 200
Omega-3 fatty acids, % 0.19
Total saturated fatty acids, % 1.56
Total monounsaturated fatty acids, % 1.6
Starch, % 31.9
Sucrose, % 3.7
Fiber (crude), % 5.1
Total digestible nutrients,% 76
Gross energy, kcal/gm 4.07
Physiological fuel value, kcal/gm 3.36
Metabolizable energy, kcal/gm 3.02
*Laboratory Rodent Chow (5001 Purina, Mills Co., USA).

Table 1: Main chemical composition of Purine 5001*.

Animals were randomly assigned to five experimental groups (ten rats per group) as shown below.

Group Control; treated with physiologic saline solution administered by intraperitoneal (i.p.) injection.

Group NutriSim©; received a single dose (10 μl/100 g of body weight, i.p.) of NutriSim©.

Group LPS; received a LD100 dose of LPS (20 mg/Kg of body weight, i.p.).

Group LPS plus NutriSim©; received a LD100 dose of LPS (20 mg/ Kg of body weight, i.p.), 15 min before NutriSim©.

Group NutriSim© plus LPS; NutriSim© was administered with a dose of NutriSim© (10 μl/100 g of body weight, i.p.) 15 min before LPS.

Animals were sacrificed at 15, 30 and 60 min after the last injection and tissues were collected immediately.

Determination of survival

In a second experimental series, rats (ten rats per group) were treated as above and survival was tested by Kaplan-Meier survival analysis also known as “Product limit”. Survival gives exact portions because it uses precise survival times. Individual times are known in which the animals die. Additionally, survival curves were compared using the log-rank test.

Morphological analysis

The organs (liver, kidney and lung) were extracted at each time point and immediately fixed by immersion with 4% paraformaldehyde in 0.1 M phosphate buffer solution (pH 7.4) at room temperature. Then they were dehydrated in graded concentrations of ethanol (70, 80, 90 and 100%); the organs were embedded in paraffin. From each organ, 4 μm thick sections were obtained and stained with hematoxylineosin to evaluate morphology and examinated under light microscope (Axioskop Zeiss photomicroscope). All sections were analyzed and the respective photomicrographs were obtained.

309523

Results and Discussion

Survival

Figure 1 shows the mortality among the group treated with LPS and the groups treated with LPS plus NutriSim©. All animals in the LPS group died within 19 hours, while in the LPS group pre-treated with NutriSim© 90% of the rats died after 21 hours. 80% of the rats treated with LPS after NutriSim© died after 23 hours. Kaplan-Meier analysis revealed a significantly shorter time-to-death among the untreated LPS group compared to the NutriSim©-treated LPS group (p<0.05). No mortality was observed in the control groups (not shown).

clinical-pathology-Kaplan-Meier-rats

Figure 1: Kaplan-Meier progression-survival for rats groups subjected to the indicated treatments.

Morphological study

Liver: No pathological changes were seen in the livers from saline and NutriSim© control groups (Figure 2). No alterations were detected in the group of rats treated with LPS after 15 minutes of treatment. However, at 30 minutes severe congestion, sinusoidal dilatation, oedema, and hypertrophy of Kupffer cells were seen. At 60 minutes, there was a moderate to severe vascular congestion, moderate cytoplasmic vacuolization, hemorrhage and cell death. In the group that was treated with LPS and subsequently received NutriSim©, we do not detect any pathological changes after 15 minutes. However, moderate cytoplasmic vacuolization was exhibited at 30 minutes, while moderate-severe cytoplasmic vacuolation and moderate-severe vascular congestion was observed at 60 minutes after treatment. The LPS group pre-treated with NutriSim© do not showed any alteration at 15 minutes. This group showed a slight congestion at 30 minutes and a moderate congestion at 60 minutes.

clinical-pathology-light-microphotographs

Figure 2: Representative light microphotographs from paraffin sections of livers at the indicated times after treatment. Control and NutriSim© control group (lane 1), LPS group (lane 2), LPS+NutriSim© group (lane 3) and NutriSim©+LPS group (lane 4). Hematoxylin-eosin stain. Original magnification: 40x.

Kidney: Light microscopic examination of Kidneys of salinecontrol rats exhibited a typical and normal structure (Figure 3), In the NutriSim© control group, no histological alterations were observed at 15 and 30 minutes, however, mild congestion of kidney was detected after 60 minutes. Among the LPS group with sepsis, the microscopic changes in the kidney tissue specimens were the following: any alterations at 15 minutes; a slight congestion and hydropic degeneration (tubular oedema) at 30 minutes; tubular oedema and moderate-severe congestion at 60 minutes of treatment. The group that received LPS and subsequently NutriSim© showed the following features: normal structure after 15 minutes; at 30 and 60 minutes exhibited mild congestion, and glomerular tubular mild oedema. The LPS group pre-treated with NutriSim© showed normal structure at 15 minutes. In addition, at 30 minutes the tissue showed oedema, congestion and mild-moderate edema and at 60 minutes the tissue had congestion and moderate-severe edema.

clinical-pathology-Hematoxylin-eosin-stain

Figure 3: Representative light microphotographs from paraffin sections of kidneys at the indicated times after treatment. Control and NutriSim© control group (lane 1), LPS group (lane 2), LPS+NutriSim© group (lane 3) and NutriSim©+LPS group (lane 4). Hematoxylin-eosin stain was used. Original magnification: 40x.

Lung: Examination of the lungs of saline and NutriSim© control groups revealed mild congestion at all the analyzed times. While LPS treatment did induce moderate and severe congestion at 30 and 60 minutes, respectively. No histological alterations were observed at 15 minutes in the group that received LPS and subsequently NutriSim©. However, at 30 minutes presents a moderate-severe congestion and at 60 minutes exhibits a severe congestion, and hyaline membrane intra alveolar exuding. The lungs from the LPS group pre-treated with NutriSim© showed mild congestion after 30 and 60 minutes of the treatment (Figure 4).

clinical-pathology-Original-magnification

Figure 4: Representative light microphotographs from paraffin sections of lungs at the indicated times after treatment. Saline and NutriSim© control groups (lane 1), LPS group (lane 2), LPS+NutriSim© group (lane 3) and NutriSim©+LPS group (lane 4). Hematoxylin-eosin stain. Original magnification: 40x.

309525

Discussion

We reported previously that intraperitoneal administration of Lipopolysaccharide (Escherichia coli, serotype 0111:B4) evoked a robust systemic response that induced a stereotypical proinflammatory cytokine release [13,15]. In addition, bacterial lipopolysaccharide induces morphological changes in many tissues [5]. It has been demonstrated that lipopolysaccharides initiates lymphocyte transformation, macrophage activation and blood coagulation [16,17], stimulates oxidative stress and pro-inflammatory molecules release from macrophages [18], leading to a state of organ failure and potential death. Multi-organ failure/dysfunction syndrome correlates with poor outcome during endotoxin shock. Therefore we also investigated organ damage in the liver, kidney and lung. In this work we demonstrate that a single dose of NutriSim© in an experimental model of septic shock induced by LPS shows effectiveness on survival rate and exerts a beneficial effect on a histological analysis in vital organs, like liver, kidney and lung.

The exact mechanism by which NutriSim© causes the molecular events able to block LPS-induced cellular damage is still far from being completely understood. It could be hypothesized that this nutritive supplement acts at a cellular level ameliorating damage caused by oxidative stress and damage induced by endotoxins, therefore increasing the survival rate. It has been demonstrated that endotoxemia can lead to higher levels of ROS and oxidative damage impairs mitochondrial function and ATPase synthase activity [19], thus leading to a possible morphological damage in vital organs. Previously, we found that NutriSim© treatment prior or after the LPS challenge significantly attenuates the end-products of lipid oxidation, restores total antioxidant capacity, the membrane fluidity and preserves mitochondrial ATPase activity [14]. Accordingly, it was found that pretreatment with NutriSim previous to the septic shock induction with LPS significantly reduced and mitigated damage to the liver and lung, whereas in the treatment of LPS previous to the NutriSim administration we found that kidney damage was reduced. The liver is one of the most important organs, it is well known that it is also the main target of lipopolysaccharides, especially Kupffer cells; these hepatic macrophages engulf lipopolysaccharides by phagocytosis [20], leading to a possible physiological as well as morphological changes. When Nutrisim was supplemented it resulted in a significantly reduced attenuation of histological damage to liver, as well as for the kidney and lung in this LPS-induced endotoxin shock model compared to the LPS group. The sampling for histological analysis was performed at short times corresponding to the observations of clinical symptoms and determination of pro-inflammatory cytokines [previous work]. In this work for the histological analysis the time for the survival determination lasted (48 hours), therefore the structural damage at this period of time appears to be more severe, as we observed in the analysis in the organs mentioned above. These pathological changes are significantly attenuated when the rats were treated with NutriSim© showing a protective effect either administering before or after the induction of septic shock with LPS.

Finally, NutriSim can attenuate the damage caused by LPS, decreasing clinical symptoms including shaggy hair, diarrhea and prostration (data not showed), In conclusion NutriSim© may have a protective effect in presence of a compromised condition, like endotoxemia.

309527

References

  1. Sharma S, Kumar A (2003) Septic shock, multiple organ failure, and acute respiratory distress syndrome. Curr Opin Pulm Med 9: 199-209.
  2. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, et al. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225.
  3. Deitch EA (1992) Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216: 117-134.
  4. García R, Díaz-Laviada I, Bosch MA, Abarca S, Portolés MT, et al. (1990) Morphological studies of cytotoxic lesions in reversible endotoxic shock. Histol Histopathol 5: 43-48.
  5. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A (1995) Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 293: 327-334.
  6. Karck U, Peters T, Decker K (1988) The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol 7: 352-361.
  7. Toledo-Pereyra LH, Suzuki S (1994) Neutrophils, cytokines, and adhesion molecules in hepatic ischemia and reperfusion injury. J Am Coll Surg 179: 758-762.
  8. Morgan ET (1997) Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 29: 1129-1188.
  9. Suliman HB, Welty-Wolf KE, Carraway M, Tatro L, Piantadosi CA (2004) Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 64: 279-288.
  10. Portolés MT, Arahuetes RM, Pagani R (1994) Intracellular calcium alterations and free radical formation evaluated by flow cytometry in endotoxin-treated rat liver Kupffer and endothelial cells. Eur J Cell Biol 65: 200-205.
  11. Berdeaux A (1993) Nitric oxide: an ubiquitous messenger. Fundam Clin Pharmacol 7: 401-411.
  12. Goraca A, Huk-Kolega H, Kleniewska P, Piechota-Polanczyk A, Skibska B (2013) Effects of lipoic acid on spleen oxidative stress after LPS administration. Pharmacol Rep 65: 179-186.
  13. Gonzalez Renovato ED, Davalos RR, Tirado LAR, Hernandez Andalon JJ, Velazquez Brizuela IE, et al. (2012) NutriSim diminishes an endotoxin-stimulated proinflammatory cytokine production, Am Journal of Biochemistry 2: 94-97.
  14. Torres Sanchez ED, Gonzalez Renovato ED, Pacheco Moises FP, Davalos RR, Tirado LAR, et al. (2013) Beneficial effect of NutriSim© against LPS-induced liver injury: Oxidative stress markers and mitochondrial ATP-ase activity. Int J Biol Chem 7: 38-46.
  15. López LC, Escames G, Ortiz F, Ros E, Acuña-Castroviejo D (2006) Melatonin restores the mitochondrial production of ATP in septic mice. Neuro Endocrinol Lett 27: 623-630.
  16. Danner RL, Elin RJ, Hossein JM, Wesley RA, Reilly JM, et al. (1991) Endotoxemia in human septic shock. Chest 99: 169-175.
  17. Morrison DC, Ulevitch RJ (1978) The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol 93: 526-618.
  18. Peavy DL, Baughn RE, Musher DM (1978) Mitogenic activity of bacterial lipopolysaccharides in vivo: morphological and functinal characterization of responding cells. Infect Immun 19: 71-78.
  19. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 265: 16330-16336.
  20. Bilzer M, Roggel F, Gerbes AL (2006) Role of Kupffer cells in host defense and liver disease. Liver Int 26: 1175-1186.

Citation: González-Renovato ED, Alatorre-Jiménez M, Bitzer-Quintero OK, Sánchez-Luna S, Flores-Alvarado LJ, et al. (2013) Effect of Nutrisim© on Endotoxic Shock Induced by Lipopolysaccharide from Escherichia coli: 0111:B4 in Rats: Structural Study of Liver, Kidney and Lung. J Clin Exp Pathol 4:153. DOI: 10.4172/2161-0681.1000153

Copyright: © 2013 González-Renovato ED, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top